摘要 |
The invention relates to the use of a mixture of gangliosides GM1, GD1a, GD1b and GT1b for the manufacture of a pharmaceutical composition for the prevention or the prophylactic treatment of general toxic effects or chronic neurotoxic effects caused by the subsequent administration of antineoplastic agents. |